TGTX logo

TG Therapeutics (TGTX) Operating expenses

annual operating expenses:

$248.59M+$49.69M(+24.98%)
December 31, 2024

Summary

  • As of today (June 2, 2025), TGTX annual total operating expenses is $248.59 million, with the most recent change of +$49.69 million (+24.98%) on December 31, 2024.
  • During the last 3 years, TGTX annual operating expenses has fallen by -$102.08 million (-29.11%).
  • TGTX annual operating expenses is now -29.11% below its all-time high of $350.67 million, reached on December 31, 2021.

Performance

TGTX Operating expenses Chart

Add series to chart
Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
series name
Suggested series

Highlights

Range

Earnings dates

OtherTGTXincome statement metrics

quarterly operating expenses:

$96.69M+$33.86M(+53.88%)
March 1, 2025

Summary

  • As of today (June 2, 2025), TGTX quarterly total operating expenses is $96.69 million, with the most recent change of +$33.86 million (+53.88%) on March 1, 2025.
  • Over the past year, TGTX quarterly operating expenses has increased by +$29.39 million (+43.67%).
  • TGTX quarterly operating expenses is now at all-time high.

Performance

TGTX quarterly operating expenses Chart

Add series to chart
Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
series name
Suggested series

Highlights

Range

Earnings dates

OtherTGTXincome statement metrics

Operating expenses Formula

Operating Expenses = Selling, General & Administrative (SG&A) Expenses + Research & Development (R&D) Expenses + Depreciation & Amortization + Other Operating Expenses

TGTX Operating expenses Trends

PeriodPeriodAnnualAnnualQuarterlyQuarterly
1 y1 year+25.0%+43.7%
3 y3 years-29.1%+40.9%
5 y5 years+46.9%+92.3%

TGTX Operating expenses Highs & Lows

PeriodPeriodAnnual vs highAnnual vs highAnnual vs lowAnnual vs lowQuarter. vs highQuarter. vs highQuarter. vs lowQuarter. vs low
3 y3-year-29.1%+25.0%at high+175.8%
5 y5-year-29.1%+46.9%at high+175.8%
alltimeall time-29.1%>+9999.0%at high+5574.9%

TGTX Operating expenses History

DateAnnualQuarterly
Mar 2025
-
$96.69M(+53.9%)
Dec 2024
$248.59M(+25.0%)
$62.84M(+1.2%)
Sep 2024
-
$62.10M(+10.2%)
Jun 2024
-
$56.35M(-16.3%)
Mar 2024
-
$67.30M(+38.5%)
Dec 2023
$198.90M(-9.9%)
$48.60M(+2.3%)
Sep 2023
-
$47.52M(-19.2%)
Jun 2023
-
$58.84M(+33.9%)
Mar 2023
-
$43.94M(-43.4%)
Dec 2022
$220.84M(-37.0%)
$77.62M(+121.4%)
Sep 2022
-
$35.05M(-11.3%)
Jun 2022
-
$39.51M(-42.4%)
Mar 2022
-
$68.65M(-27.8%)
Dec 2021
$350.67M(+28.1%)
$95.06M(+9.4%)
Sep 2021
-
$86.87M(+10.1%)
Jun 2021
-
$78.89M(-12.2%)
Mar 2021
-
$89.86M(+3.5%)
Dec 2020
$273.75M(+61.8%)
$86.82M(+1.2%)
Sep 2020
-
$85.76M(+68.5%)
Jun 2020
-
$50.88M(+1.2%)
Mar 2020
-
$50.28M(+32.3%)
Dec 2019
$169.21M(-3.1%)
$38.00M(-37.6%)
Sep 2019
-
$60.90M(+71.2%)
Jun 2019
-
$35.58M(+2.5%)
Mar 2019
-
$34.73M(-35.9%)
Dec 2018
$174.55M(+46.9%)
$54.19M(+57.7%)
Sep 2018
-
$34.37M(-22.6%)
Jun 2018
-
$44.38M(+6.7%)
Mar 2018
-
$41.62M(+33.9%)
Dec 2017
$118.86M(+50.2%)
$31.07M(-1.7%)
Sep 2017
-
$31.62M(+11.1%)
Jun 2017
-
$28.46M(+2.7%)
Mar 2017
-
$27.70M(+15.1%)
Dec 2016
$79.12M(+24.9%)
$24.07M(-3.6%)
Sep 2016
-
$24.96M(+55.4%)
Jun 2016
-
$16.06M(+14.5%)
Mar 2016
-
$14.03M(-20.6%)
Dec 2015
$63.33M(+13.3%)
$17.68M(+27.5%)
Sep 2015
-
$13.86M(-19.2%)
Jun 2015
-
$17.15M(+17.1%)
Mar 2015
-
$14.64M(-22.0%)
Dec 2014
$55.87M(+175.0%)
$18.76M(+7.3%)
Sep 2014
-
$17.48M(+45.7%)
Jun 2014
-
$11.99M(+56.9%)
Mar 2014
-
$7.64M(+46.5%)
Dec 2013
$20.32M(-21.3%)
$5.22M(+11.3%)
Sep 2013
-
$4.69M(-29.7%)
Jun 2013
-
$6.67M(+77.7%)
Mar 2013
-
$3.75M(+44.0%)
Dec 2012
$25.81M(+2826.2%)
$2.60M(-4.0%)
Sep 2012
-
$2.71M(-12.6%)
Jun 2012
-
$3.10M(-82.1%)
Mar 2012
-
$17.39M(+3033.1%)
Dec 2011
$882.00K(-56.3%)
$554.90K(+1743.5%)
Sep 2011
-
$30.10K(-89.9%)
Jun 2011
-
$297.00K(-98.4%)
Mar 2011
-
$18.27M(+3990.3%)
Dec 2010
$2.02M
$446.60K(-13.4%)
DateAnnualQuarterly
Sep 2010
-
$515.60K(-1.8%)
Jun 2010
-
$525.10K(-0.8%)
Mar 2010
-
$529.40K(+55.1%)
Dec 2009
$1.77M(-59.9%)
$341.30K(-13.7%)
Sep 2009
-
$395.60K(-17.1%)
Jun 2009
-
$477.30K(-14.4%)
Mar 2009
-
$557.30K(-1165.6%)
Dec 2008
$4.41M(-63.7%)
-$52.30K(-103.8%)
Sep 2008
-
$1.38M(-5.7%)
Jun 2008
-
$1.47M(-9.1%)
Mar 2008
-
$1.61M(-15.9%)
Dec 2007
$12.14M(+21.4%)
$1.92M(-29.1%)
Sep 2007
-
$2.71M(-45.0%)
Jun 2007
-
$4.92M(+89.8%)
Mar 2007
-
$2.59M(-18.4%)
Dec 2006
$10.00M(-48.3%)
$3.18M(+61.8%)
Sep 2006
-
$1.97M(-16.6%)
Jun 2006
-
$2.36M(-5.6%)
Mar 2006
-
$2.50M(-82.8%)
Dec 2005
$19.36M(+215.1%)
$14.53M(+680.4%)
Sep 2005
-
$1.86M(+23.3%)
Jun 2005
-
$1.51M(+3.6%)
Mar 2005
-
$1.46M(-18.7%)
Dec 2004
$6.14M(+29.1%)
$1.79M(-20.1%)
Sep 2004
-
$2.24M(+127.2%)
Jun 2004
-
$986.70K(-12.1%)
Mar 2004
-
$1.12M(-26.2%)
Dec 2003
$4.76M(+367.3%)
$1.52M(-25.4%)
Sep 2003
-
$2.04M(+162.4%)
Jun 2003
-
$777.00K(+84.0%)
Mar 2003
-
$422.20K(-163.2%)
Dec 2002
$1.02M(-72.8%)
-$668.30K(-213.6%)
Sep 2002
-
$588.20K(+136.4%)
Jun 2002
-
$248.80K(-60.5%)
Mar 2002
-
$629.60K(+12.8%)
Dec 2001
$3.74M(-16.3%)
$558.20K(-20.8%)
Sep 2001
-
$704.50K(-40.2%)
Jun 2001
-
$1.18M(+33.8%)
Mar 2001
-
$880.70K(-149.9%)
Dec 2000
$4.46M(+43.9%)
-$1.77M(-247.6%)
Sep 2000
-
$1.20M(-64.8%)
Jun 2000
-
$3.40M(+110.8%)
Mar 2000
-
$1.61M(+101.7%)
Dec 1999
$3.10M(-47.5%)
$800.00K(+33.3%)
Sep 1999
-
$600.00K(-14.3%)
Jun 1999
-
$700.00K(-30.0%)
Mar 1999
-
$1.00M(-33.3%)
Dec 1998
$5.90M(+7.3%)
$1.50M(+15.4%)
Sep 1998
-
$1.30M(-23.5%)
Jun 1998
-
$1.70M(+21.4%)
Mar 1998
-
$1.40M(-17.6%)
Dec 1997
$5.50M(+103.7%)
$1.70M(+54.5%)
Sep 1997
-
$1.10M(-38.9%)
Jun 1997
-
$1.80M(+100.0%)
Mar 1997
-
$900.00K(>+9900.0%)
Dec 1996
$2.70M
$0.00(-100.0%)
Sep 1996
-
$1.20M(+71.4%)
Jun 1996
-
$700.00K

FAQ

  • What is TG Therapeutics annual total operating expenses?
  • What is the all time high annual operating expenses for TG Therapeutics?
  • What is TG Therapeutics annual operating expenses year-on-year change?
  • What is TG Therapeutics quarterly total operating expenses?
  • What is the all time high quarterly operating expenses for TG Therapeutics?
  • What is TG Therapeutics quarterly operating expenses year-on-year change?

What is TG Therapeutics annual total operating expenses?

The current annual operating expenses of TGTX is $248.59M

What is the all time high annual operating expenses for TG Therapeutics?

TG Therapeutics all-time high annual total operating expenses is $350.67M

What is TG Therapeutics annual operating expenses year-on-year change?

Over the past year, TGTX annual total operating expenses has changed by +$49.69M (+24.98%)

What is TG Therapeutics quarterly total operating expenses?

The current quarterly operating expenses of TGTX is $96.69M

What is the all time high quarterly operating expenses for TG Therapeutics?

TG Therapeutics all-time high quarterly total operating expenses is $96.69M

What is TG Therapeutics quarterly operating expenses year-on-year change?

Over the past year, TGTX quarterly total operating expenses has changed by +$29.39M (+43.67%)
On this page